Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
3226
DELISTED
Everi Holdings
EVRI
| $3.59M | ﹤0.01% |
260,158
-348,548
| -57% | -$3.79M |
|
|
VNE
3227
DELISTED
Veoneer, Inc.
VNE
| $3.59M | ﹤0.01% |
168,485
-86,570
| -34% | -$1.64M |
|
|
DISH
3228
DELISTED
DISH Network Corp.
DISH
| $3.59M | ﹤0.01% |
110,926
-566,758
| -84% | -$17.4M |
|
3229
CALL
Trip.com Group
TCOM
$29.1B
| $3.58M | ﹤0.01% |
106,300
-2,200
| -2% | -$71.7K |
|
3230
Grupo Cibest SA
CIB
$21.1B
| $3.58M | ﹤0.01% |
89,118
-23,787
| -21% | -$743K |
|
3231
First Trust Value Line Dividend Fund
FVD
$8.4B
| $3.58M | ﹤0.01% |
102,111
+52,111
| +104% | +$1.76M |
|
3232
Invesco Pharmaceuticals ETF
PJP
$498M
| $3.58M | ﹤0.01% |
50,133
| – | – |
|
3233
BioAtla
BCAB
$5.74M
| $3.57M | ﹤0.01% |
+2,100
| New | +$3.51M |
|
3234
Live Oak Bancshares
LOB
$1.97B
| $3.57M | ﹤0.01% |
75,180
+11,436
| +18% | +$458K |
|
3235
Seneca Foods Class A
SENEA
$1.21B
| $3.56M | ﹤0.01% |
89,344
-7,633
| -8% | -$309K |
|
|
DX
3236
CALL
Dynex Capital
DX
$3.21B
| $3.56M | ﹤0.01% |
200,000
| – | – |
|
|
DX
3237
PUT
Dynex Capital
DX
$3.21B
| $3.56M | ﹤0.01% |
200,000
| – | – |
|
|
POLY
3238
DELISTED
Plantronics, Inc.
POLY
| $3.56M | ﹤0.01% |
131,681
-29,713
| -18% | -$652K |
|
|
GNRS
3239
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
| $3.55M | ﹤0.01% |
+350,000
| New | +$3.46M |
|
3240
Encore Capital Group
ECPG
$2.13B
| $3.54M | ﹤0.01% |
91,031
-46,641
| -34% | -$1.7M |
|
|
GRSV
3241
DELISTED
Gores Holdings V, Inc.
GRSV
| $3.54M | ﹤0.01% |
+340,000
| New | +$3.4M |
|
3242
Mesa Laboratories
MLAB
$574M
| $3.53M | ﹤0.01% |
12,304
-64,502
| -84% | -$17.7M |
|
3243
Sunstone Hotel Investors
SHO
$2.06B
| $3.5M | ﹤0.01% |
309,306
-443,344
| -59% | -$4.24M |
|
3244
Corsair Gaming
CRSR
$1.55B
| $3.5M | ﹤0.01% |
96,748
-112,922
| -54% | -$3.44M |
|
|
BFX
3245
DELISTED
BowFlex Inc.
BFX
| $3.5M | ﹤0.01% |
193,007
-889
| -0.5% | -$18.5K |
|
3246
PUT
Five Below
FIVE
$13.5B
| $3.5M | ﹤0.01% |
+20,000
| New | +$2.96M |
|
3247
Telos
TLS
$358M
| $3.5M | ﹤0.01% |
+106,000
| New | +$2.53M |
|
3248
Vident US Equity Strategy ETF
VUSE
$691M
| $3.48M | ﹤0.01% |
100,000
| – | – |
|
|
SNP
3249
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $3.48M | ﹤0.01% |
78,146
+27,761
| +55% | +$1.2M |
|
3250
Jasper Therapeutics
JSPR
$23.6M
| $3.48M | ﹤0.01% |
34,800
-17,126
| -33% | -$1.7M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.